The impact of body mass index and type 2 diabetes on breast cancer: Current therapeutic measures of prevention

F. Resta, V. Triggiani, C. Sabbà, B. Licchelli, S. Ghiyasaldin, A. Liso, F. Schittulli, M. Quaranta, A. Paradiso, E. Tafaro, E. Guastanacchia

Research output: Contribution to journalArticle

Abstract

Epidemiological data have suggested a possible relationship between obesity, diabetes mellitus and cancer risk, particularly breast cancer. We set out to investigate the effect of body mass index and diabetes mellitus on the presence of breast cancer in the Apulian population. We selected 1,663 women affected with primary breast cancer and 4,702 control patients. All patients with breast cancer underwent surgical excision of the tumor and their tumors were histologically confirmed. The prevalence of type 2 diabetes (8%) in the women affected by breast cancer was significantly higher than in the control group (5%) (p25, both in premenopause and in postmenopause. With respect to BMI, the non-diabetic patients with breast cancer in postmenopause showed the same pattern as the diabetic ones. Instead, among the women in premenopause a higher percentage (55%) of patients with a BMI

Original languageEnglish
Pages (from-to)327-333
Number of pages7
JournalCurrent Drug Targets: Immune, Endocrine and Metabolic Disorders
Volume4
Issue number4
DOIs
Publication statusPublished - Dec 2004

Fingerprint

Type 2 Diabetes Mellitus
Body Mass Index
Breast Neoplasms
Premenopause
Postmenopause
Diabetes Mellitus
Therapeutics
Neoplasms
Obesity
Control Groups
Population

Keywords

  • Body mass index
  • Breast cancer
  • Diabetes
  • Menopause

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy

Cite this

The impact of body mass index and type 2 diabetes on breast cancer : Current therapeutic measures of prevention. / Resta, F.; Triggiani, V.; Sabbà, C.; Licchelli, B.; Ghiyasaldin, S.; Liso, A.; Schittulli, F.; Quaranta, M.; Paradiso, A.; Tafaro, E.; Guastanacchia, E.

In: Current Drug Targets: Immune, Endocrine and Metabolic Disorders, Vol. 4, No. 4, 12.2004, p. 327-333.

Research output: Contribution to journalArticle

Resta, F, Triggiani, V, Sabbà, C, Licchelli, B, Ghiyasaldin, S, Liso, A, Schittulli, F, Quaranta, M, Paradiso, A, Tafaro, E & Guastanacchia, E 2004, 'The impact of body mass index and type 2 diabetes on breast cancer: Current therapeutic measures of prevention', Current Drug Targets: Immune, Endocrine and Metabolic Disorders, vol. 4, no. 4, pp. 327-333. https://doi.org/10.2174/1568008043339686
Resta, F. ; Triggiani, V. ; Sabbà, C. ; Licchelli, B. ; Ghiyasaldin, S. ; Liso, A. ; Schittulli, F. ; Quaranta, M. ; Paradiso, A. ; Tafaro, E. ; Guastanacchia, E. / The impact of body mass index and type 2 diabetes on breast cancer : Current therapeutic measures of prevention. In: Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 2004 ; Vol. 4, No. 4. pp. 327-333.
@article{ace397feaae84e5994c23075897fa736,
title = "The impact of body mass index and type 2 diabetes on breast cancer: Current therapeutic measures of prevention",
abstract = "Epidemiological data have suggested a possible relationship between obesity, diabetes mellitus and cancer risk, particularly breast cancer. We set out to investigate the effect of body mass index and diabetes mellitus on the presence of breast cancer in the Apulian population. We selected 1,663 women affected with primary breast cancer and 4,702 control patients. All patients with breast cancer underwent surgical excision of the tumor and their tumors were histologically confirmed. The prevalence of type 2 diabetes (8{\%}) in the women affected by breast cancer was significantly higher than in the control group (5{\%}) (p25, both in premenopause and in postmenopause. With respect to BMI, the non-diabetic patients with breast cancer in postmenopause showed the same pattern as the diabetic ones. Instead, among the women in premenopause a higher percentage (55{\%}) of patients with a BMI",
keywords = "Body mass index, Breast cancer, Diabetes, Menopause",
author = "F. Resta and V. Triggiani and C. Sabb{\`a} and B. Licchelli and S. Ghiyasaldin and A. Liso and F. Schittulli and M. Quaranta and A. Paradiso and E. Tafaro and E. Guastanacchia",
year = "2004",
month = "12",
doi = "10.2174/1568008043339686",
language = "English",
volume = "4",
pages = "327--333",
journal = "Current Drug Targets: Immune, Endocrine and Metabolic Disorders",
issn = "1568-0088",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - The impact of body mass index and type 2 diabetes on breast cancer

T2 - Current therapeutic measures of prevention

AU - Resta, F.

AU - Triggiani, V.

AU - Sabbà, C.

AU - Licchelli, B.

AU - Ghiyasaldin, S.

AU - Liso, A.

AU - Schittulli, F.

AU - Quaranta, M.

AU - Paradiso, A.

AU - Tafaro, E.

AU - Guastanacchia, E.

PY - 2004/12

Y1 - 2004/12

N2 - Epidemiological data have suggested a possible relationship between obesity, diabetes mellitus and cancer risk, particularly breast cancer. We set out to investigate the effect of body mass index and diabetes mellitus on the presence of breast cancer in the Apulian population. We selected 1,663 women affected with primary breast cancer and 4,702 control patients. All patients with breast cancer underwent surgical excision of the tumor and their tumors were histologically confirmed. The prevalence of type 2 diabetes (8%) in the women affected by breast cancer was significantly higher than in the control group (5%) (p25, both in premenopause and in postmenopause. With respect to BMI, the non-diabetic patients with breast cancer in postmenopause showed the same pattern as the diabetic ones. Instead, among the women in premenopause a higher percentage (55%) of patients with a BMI

AB - Epidemiological data have suggested a possible relationship between obesity, diabetes mellitus and cancer risk, particularly breast cancer. We set out to investigate the effect of body mass index and diabetes mellitus on the presence of breast cancer in the Apulian population. We selected 1,663 women affected with primary breast cancer and 4,702 control patients. All patients with breast cancer underwent surgical excision of the tumor and their tumors were histologically confirmed. The prevalence of type 2 diabetes (8%) in the women affected by breast cancer was significantly higher than in the control group (5%) (p25, both in premenopause and in postmenopause. With respect to BMI, the non-diabetic patients with breast cancer in postmenopause showed the same pattern as the diabetic ones. Instead, among the women in premenopause a higher percentage (55%) of patients with a BMI

KW - Body mass index

KW - Breast cancer

KW - Diabetes

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=7444221291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444221291&partnerID=8YFLogxK

U2 - 10.2174/1568008043339686

DO - 10.2174/1568008043339686

M3 - Article

C2 - 15578984

AN - SCOPUS:7444221291

VL - 4

SP - 327

EP - 333

JO - Current Drug Targets: Immune, Endocrine and Metabolic Disorders

JF - Current Drug Targets: Immune, Endocrine and Metabolic Disorders

SN - 1568-0088

IS - 4

ER -